Vaccines activating cancers (opens in new tab)

By Prof Angus Dalgleish MD FRCP FRACP FRCPath FMedSci My name is Professor Angus Dalgleish\. I am an oncologist and immunologist with decades of experience in cancer immunotherapy and HIV research, including early clinical use of cancer immunotherapy in the United Kingdom long before checkpoint inhibitors were approved\. I am Professor Emeritus and Foundation Chair of Oncology at the University of London, and Principal of the Institute of Cancer Vaccines and Immunotherapy\. Beginning in late ...